View Older Stories View More Recent Stories

Aug 29, 2024 08:21AM VivoPower's (VVPR) Tembo E-LV Executes a Definitive Merger Agreement with Cactus Acquisition Corp. 1 (CCTS)
Aug 29, 2024 08:20AM Tembo E-LV, a subsidiary of Nasdaq-listed VivoPower International PLC (“VVPR”) executes a definitive Business Combination Agreement with CCTS for a combined enterprise value of US$904 million
Aug 29, 2024 08:00AM Flamingo Therapeutics Announces Participation in Upcoming Investor Conferences
Aug 28, 2024 09:00AM Editas Medicine to Participate in Upcoming Investor Conferences
Aug 28, 2024 08:00AM Prime Medicine to Participate in Upcoming Investor Conferences
Aug 28, 2024 08:00AM Vor Bio to Participate in Upcoming Investor Conferences
Aug 27, 2024 08:00AM Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
Aug 22, 2024 07:52AM Allurion Technologies (ALUR) PT Lowered to $2.50 at Chardan Capital Markets
Aug 21, 2024 05:36AM Chardan Capital Markets Starts Clearside Biomedical (CLSD) at Buy
Aug 19, 2024 09:00AM Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Aug 15, 2024 06:17AM Avidity Biosciences Inc. (RNA) Prices Upsized 7.32M Share Offering at $41/sh
Aug 14, 2024 08:30PM Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
Aug 14, 2024 08:35AM Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Aug 14, 2024 05:50AM Chardan Capital Markets Assumes Zura Bio Ltd. (ZURA) at Buy
Jul 31, 2024 04:01PM Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias
Jul 31, 2024 05:44AM Chardan Capital Markets Assumes MeiraGTx Holdings plc (MGTX) at Buy
Jul 30, 2024 07:55AM Pershing Square USA, Ltd. Announces Proposed IPO Size
Jul 17, 2024 01:07PM Chardan Capital Markets Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Jul 16, 2024 10:00AM Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference
Jul 9, 2024 12:13PM Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”
Jul 9, 2024 08:31AM ReShape Lifesciences Inc. (RSLS) to Merge with Vyome Therapeutics, Enters Asset Purchase Agreement With Biorad Medisys
Jul 9, 2024 08:31AM ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
Jul 9, 2024 06:28AM Pershing Square USA, Ltd. Announces Launch of IPO Roadshow
Jul 8, 2024 06:32AM Chardan Capital Markets Starts Cargo Therapeutics (CRGX) at Buy
Jun 28, 2024 08:00AM Eyenovia Inc (EYEN) Prices 7.56M Share Offering at $0.66/sh
Jun 28, 2024 08:00AM Eyenovia Announces Pricing of $5M Registered Direct Offering
Jun 27, 2024 05:36PM Form SC 13G ANEW Medical, Inc. Filed by: CHARDAN CAPITAL MARKETS LLC
Jun 21, 2024 04:45PM ANEW MEDICAL, INC. and REDWOOD ACQUISITION CORP. ANNOUNCE CLOSING OF THEIR BUSINESS COMBINATION
Jun 17, 2024 11:50AM TechMediaBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Management Presents During Chardan Transport Platform Tech Series
Jun 17, 2024 11:16AM TechMediaBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Completes Presentation at Chardan Transport Platform Tech Series
Jun 14, 2024 09:00AM Freight Technologies Inc. Participates in Chardan's Transport Platform Tech Series
Jun 6, 2024 04:08PM Chardan Capital Markets Starts Cognition Therapeutics (CGTX) at Buy
May 28, 2024 07:00AM AtlasClear Holdings, Inc. Announces First Quarter 2024 Financial Results
May 28, 2024 05:34AM Chardan Capital Markets Starts iBio, Inc. (IBIO) at Buy
May 22, 2024 08:35AM Sonnet BioTherapeutics (SONN) Announces Review of Strategic Alternatives
May 22, 2024 07:00AM Sonnet BioTherapeutics Announces Review of Strategic Alternatives
May 15, 2024 02:16PM AB Science reports its revenues for the year 2023 and provides an update on its activities
May 14, 2024 04:15PM Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update
May 9, 2024 05:26PM Xtribe, Technology-driven Geolocation-based Commerce Platform, to Go Public on Nasdaq through Proposed Business Combination with WinVest Acquisition Corp. (NASDAQ: WINV)
May 7, 2024 01:30AM GenSight Biologics Announces a Successful Offering for an Amount Over €9.2 Million
May 1, 2024 04:05PM Surf Air Mobility Participates in Chardan’s Virtual Transport Platform Tech Series
Apr 30, 2024 06:01AM Iovance Biotherapeutics to Present at Upcoming Conferences
Apr 24, 2024 04:30PM MeiraGTx to Participate in Upcoming Investor Conferences
Apr 24, 2024 07:05AM REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Apr 23, 2024 07:00AM Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Apr 22, 2024 07:45AM Chardan Capital Markets Assumes Prime Medicine (PRME) at Buy
Apr 22, 2024 07:00AM Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Apr 15, 2024 05:00PM Myeloid Therapeutics to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Apr 12, 2024 07:57PM Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
Apr 8, 2024 05:30AM Chardan Capital Markets Downgrades Energy Vault Holdings Inc. (NRGV) to Sell
View More Recent Stories View Older Stories